From BioHealth Investor
Biotechnology
IDERA PHARMACEUTICAL [IDP] +13.53%
RENOVIS INC [RNVS] +10.16%
COMBINATORX [CRXX] +9.92%
IMMUNE RESPONSE NEW [IMRP.OB] +9.86%
HANA BIOSCIENCES INC [HNAB] +8.90%
Diagnostic Substances
HEALTHCARE TECH LTD [HCTL] +26.40%
RG GLBL LIFESTYLS [RGBL.OB] +12.50%
MONOGRAM BIOSCIENCES [MGRM] +9.80%
ADVANCE MAGNETIC [AMAG] +4.80%
MYRIAD GENETICS [MYGN] +4.57%
Drug Delivery
INSITE VISION INC [ISV] +2.76%
PETMED EXPRESS INC [PETS] +2.67%
FLAMEL TECH SA ADR [FLML] +2.23%
GENEREX BIOTECH CORP [GNBT] +1.78%
BIOVAIL CORP [BVF] +1.65%
Drug Manufacturers
MARSHALL EDWARDS [MSHL] +20.73%
EXEGENICS INC [EXEG.OB] +18.18%
TELIK INC [TELK] +9.16%
NOVOGEN LTD ADS [NVGN] +7.73%
GENTIUM SPA ADS [GENT] +6.82%
Medical Appliances & Equipment
MEDICOR LTD [MDCR.OB] +26.00%
ESCALON MED CP [ESMC] +12.61%
DIGIRAD CORPORATION [DRAD] +9.40%
CELSION CORP [CLN] +6.30%
STEREOTAXIS, INC. [STXS] +6.00%
Medical Instruments & Supplies
DTLL INC [DTLI.OB] +23.33%
EP MEDSYSTEMS INC [EPMD] +9.46%
VIVUS INC [VVUS] +5.54%
CARDICA, INC. [CRDC] +4.56%
MESA LABS INC [MLAB] +4.27%
Medical Laboratories & Research
BIO-IMAGING TECH [BITI] +9.99%
OSI PHARMACEUTIC [OSIP] +5.05%
ENZO BIOCHEM INC [ENZ] +4.46%
ERESEARCHTECHNOLOG [ERES] +2.91%
BIO-REFERENCE LAB [BRLI] +2.69%
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
